Last updated 12 days ago

MK-5475-013 INSIGNIA-PH-COPD: A Study of the Efficacy and Safety of MK-5475 (an Inhaled sGC Stimulator) in Adults With PH-COPD

120 patients around the world
Available in Spain, Colombia, United States, Argentina
Merck Sharp & Dohme LLC
5Research sites
120Patients around the world
This study is for people with
Chronic obstructive pulmonary disease
Copd
Requirements for the patient
To 85 Years
All Gender
Medical requirements
Sites
Centro Médico Capital
Recruiting
Av. 60 462, B1904 La Plata, Provincia de Buenos Aires
Fundación Respirar
Recruiting
Av. Cabildo 1548, CABA, Buenos Aires
Fundación Valle del Lili
Recruiting
Av. Simón Bolívar. Cra 98 # 18-49, Cali, Valle del Cauca
Clínica Cardiovascular Santa María
Recruiting
CL 78B #75-21, Medellín, Robledo, Medellín, Antioquia
Ciensalud Ips S A S
Recruiting
CALLE 50 20 91 INTERIOR CIENSALUD, BARRANQUILLA, ATLANTICO
Trialtech
About usOur missionOur teamPartnersFAQs
Medical newsLatest newsStudiesInterviewsTestimonials
ProductsUEPM OncoUEPM Physicians
LinksDownloads
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy